Insmed Incorporated

INSM: NasdaqGS
37Total

Lowest reading is at 4 out of 100. All scores are out of 100.

About The Company

CEO

Mr. William H. Lewis J.D., M.B.A.

Market Cap

21.02 Billion USD

Sector

Healthcare

Website

https://www.insmed.com

Last Update

15/10/2026, 01:07:56

Description

Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Read More

Strongest readings

  • ✔Cashflow and earnings growth is strong (growth score 85 out of 100)
  • ✔Altman-Z score of 4.39 sits above the distress range
  • ✔Debt is low at 0.73 times equity

Weakest readings

  • ✘Returns on capital have declined over five years (20.77% lower)
  • ✘Share count has been rising at 15.31% per year
  • ✘Income is not covering expenditure and investment (free cashflow -3.70 per share)
  • ✘Earnings are negative at -6.42 per share
  • ✘Priced well above the cashflow it produces (value score 4 out of 100)

Key Figures

StatusMetricValueReadingMarket avg
Price / earnings (TTM)
N/A19.60x
✘
Margin of safety (DCF)
-96.55%
17.95%
✔
Revenue growth (5y average)
24.39%
10.97%
✘
Dividend yield (TTM)
0.00%
1.85%
✘
Share count, per year
15.31%
0.00%
✘Return on capital employed-66.50%
10.00%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

Valuation

4 / 100

Priced above the market on most measures.

StatusMetricValueReadingMarket avg
Price / earnings
N/A19.60x
✘Free cashflow yield-3.68%
4.70%
Price / earnings growthN/A1.50x
Price / book29.00x
—
✘
Margin of safety
-96.55%
17.95%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

  • ✘Estimated intrinsic value of 3.47 USD is below the current price of 96.27 USD

Desired Margin Of Safety

0%

▼

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Estimated Fair Value: N/A✘

Current Price: 100.6 USD

Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated fair value for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel for the impact this has on longterm investment returns and find a margin of safety you are comfortable with.

Growth

85 / 100

Growing faster than the market on most measures.

StatusMetricValueReadingMarket avg
✔
Revenue growth
24.39%
10.97%
Earnings growthN/A14.48%
Cashflow growthN/A12.35%

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

  • ✔Revenue growth has improved this year (185.76% against a five year average of 24.39%)

Health

45 / 100

Balance sheet is stretched on several measures.

Measured on Leverage and capital, Funding and liquidity, Earnings quality.

StatusMetricValueReadingThreshold
✔Altman-Z score4.39
3.00
✘Piotroski score4.00
5.00
✔Debt / equity0.73x
0.80x
✔Current ratio3.83x
1.00x
✘Interest coverage-14.25x
2.50x
✘Free cashflow / debt0.00x
0.15x
✔Debt / capital0.42x
1.00x

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

  • ✘Income is not covering expenditure and investment (free cashflow -3.70 per share)

Management

16 / 100

Returns on capital are below the market.

StatusMetricValueReadingMarket avg
✘Return on equity-172.78%
15.00%
✘Return on capital employed-66.50%
10.00%
Return on assets-56.38%
—
Free cashflow return on capital-53.88%
—
✘Return on capital, 5y change-20.77%
0.00%
✘
Share count, per year
15.31%
0.00%
✘Share count, recent9.73%
0.00%
Realized buyback returnN/A0.00%
✔Goodwill erosion / equity0.00%
2.00%
Price volatility, 5 year61.92%
—

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

  • ✔New shares were issued while the value score was 4 out of 100

Analysts

not enough data
StatusMetricValueReadingNeutral
Analyst opinion scoreN/A50

The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.

Financial History

Annual figures across the full reporting history we hold.

Market Peers

INSM

SEC Filings

Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

See 35+ Years Annual Reports

Other Information

Company Name

Insmed Incorporated

Currency

USD

Beta

0.817

Vol Avg

2474628

Ceo

Mr. William H. Lewis J.D., M.B.A.

Cik

0001104506

Cusip

Exchange

NasdaqGS

Full Time Employees

1664

Industry

Biotechnology

Sector

Healthcare

Ipo Date

Address

700 US Highway 202/206

City

Bridgewater

State

NJ

Country

United States

Zip

08807

Phone

908 977 9900

Analysis Last Updated

15/10/2026, 01:07:56

Financial data compiled from SEC EDGAR filings and Yahoo Finance.

Noticed an error with something on our site?

Data, not advice. Do your own diligence.

We Use Cookies